Pharmacogenomics Services Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2028

The global Pharmacogenomics Services market size is projected to reach US$ 8155 million by 2028, from US$ 4989 million in 2021, at a CAGR of 7% during 2022-2028. Pharmacogenomics services have transformed the medical industry. By extending these services to consumer-to-consumer direct testing, we have broadened our scope to include the global medical spectrum and further customized our treatment modules.

Data by Type
Genotyping
SNP Identification
Pharmacogenetic Testing
Others

Data by Application
Oncology
Infectious Diseases
Psychiatry
Cardiovascular
Others

Top Major Key Players:
Abbott Laboratories
Admera Health, LLC
Mesa Laboratories, Inc.
Dynamic DNA Laboratories
F. Hoffmann-La Roche Ltd.
GeneOmbio Technologies Pvt Ltd.
Exact Sciences Corporation
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
OmeCare
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Precipio
23andMe, Inc.
OneOme, LLC
DiaCarta, Inc.
OPKO Health

Scope of the Report

The research study analyzes the global Pharmacogenomics Services Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Pharmacogenomics Services Market Report

1. What was the Pharmacogenomics Services Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Pharmacogenomics Services Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Pharmacogenomics Services Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.